NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, March 6th. Investors of record on Tuesday, April 23rd will be given a dividend of $0.50 per share on Friday, May 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 3.60%. The ex-dividend date is Monday, April 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its quarterly earnings results on Wednesday, February, 20th. The pharmacy operator reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.07 by $0.07. The pharmacy operator earned $54.42 billion during the quarter, compared to analyst estimates of $53.78 billion. CVS Health had a negative net margin of 0.31% and a positive return on equity of 17.49%. The company's revenue for the quarter was up 12.5% on a year-over-year basis. During the same period last year, the firm posted $1.92 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of $6.68-6.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.34. CVS Health also updated its FY 2019 guidance to $6.68-6.88 EPS.

18 equities research analysts have issued twelve-month price targets for CVS Health's shares. Their forecasts range from $68.00 to $100.00. On average, they anticipate CVS Health's stock price to reach $84.1765 in the next twelve months. This suggests a possible upside of 51.4% from the stock's current price. View Analyst Price Targets for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News coverage about CVS stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news sentiment score of 1.1 on InfoTrie's scale. They also gave headlines about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future.

Some companies that are related to CVS Health include Home Depot (HD), Mcdonald's (MCD), Costco Wholesale (COST), INDUSTRIA DE DI/ADR (IDEXY), Starbucks (SBUX), Lowe's Companies (LOW), Booking (BKNG), KERING S A/ADR (PPRUY), TJX Companies (TJX), Walgreens Boots Alliance (WBA), Wal-mart de Mexico S A B de C V (WMMVY), Target (TGT), COMPAGNIE FINAN/ADR (CFRUY), SEVEN & I HOLDI/ADR (SVNDY) and COMPASS GRP PLC/S (CMPGY).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bank of America (BAC), General Electric (GE), Cisco Systems (CSCO), Alibaba Group (BABA), NVIDIA (NVDA), Intel (INTC) and Starbucks (SBUX).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.12%), FMR LLC (3.85%), Oregon Public Employees Retirement Fund (2.46%), Barrow Hanley Mewhinney & Strauss LLC (1.88%), Northern Trust Corp (1.76%) and Geode Capital Management LLC (1.62%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Norges Bank, FMR LLC, Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp and Dimensional Fund Advisors LP. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $55.60.

CVS Health has a market capitalization of $72.12 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]